SOUTH SAN FRANCISCO, Calif., April 17 /PRNewswire-FirstCall/ -- Pain Therapeutics, Inc. , a biopharmaceutical company, today announced that management will present at the UBS Global Specialty Pharmaceuticals Conference in New York on Monday, April 24th at 2:00 p.m. Eastern Time.
An audio webcast of the live presentation will be open to all on the Pain Therapeutics web site, www.paintrials.com. A replay will also be available after the live event through May 9, 2006.
About Pain Therapeutics, Inc.
Pain Therapeutics is a biopharmaceutical company that develops novel drugs. We have two investigational drug candidates, Remoxy(TM) and Oxytrex(TM), in Phase III clinical programs. Both drugs target different segments of the multi-billion dollar market to treat severe chronic pain, such as persistent low-back pain or pain due to advanced stages of osteoarthritis.
Pain Therapeutics, Inc.CONTACT: Christi Waarich, Senior Manager of Investor Relations of PainTherapeutics, Inc., +1-650-825-3324, or cwaarich@paintrials.com; or CarneyDuntsch (Media) of Burns McClellan, +1-212-213-0006, for Pain Therapeutics,Inc.
Web site: http://www.paintrials.com/
